Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Curis, Inc.
Curis, Inc.
Janssen Research & Development, LLC
Syndax Pharmaceuticals
Taiho Oncology, Inc.
CareDx
Shattuck Labs, Inc.
AstraZeneca
MEI Pharma, Inc.
Novartis
Seagen Inc.
Sellas Life Sciences Group
Crossbow Therapeutics, Inc.
AvenCell Therapeutics, Inc.
Novartis
Kura Oncology, Inc.
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Gyala Therapeutics
Pfizer
Caribou Biosciences, Inc.
Janssen Research & Development, LLC
Taiho Oncology, Inc.
Stemline Therapeutics, Inc.
Bristol-Myers Squibb
AbbVie
Sichuan Baili Pharmaceutical Co., Ltd.
BeOne Medicines
Orca Biosystems, Inc.
Astellas Pharma Inc
Genmab
Auron Therapeutics, Inc.
Tempus AI
Daiichi Sankyo
Gamida Cell ltd
Servier
Ossium Health, Inc.
Ossium Health, Inc.
Orca Biosystems, Inc.
Biomea Fusion Inc.
Carevive Systems, Inc.
Orca Biosystems, Inc.
Faron Pharmaceuticals Ltd
Celgene
Syndax Pharmaceuticals
Senti Biosciences
AbbVie
Bristol-Myers Squibb
Beijing InnoCare Pharma Tech Co., Ltd.
Bristol-Myers Squibb
iOMEDICO AG